Neuronetics, Inc. (STIM) 10-Year Financial Performance & Capital Metrics

STIM • • Industrial / General

HealthcareDiagnostics & ResearchDigital Health & Point-of-Care DiagnosticsDigital Therapeutics & Remote Monitoring

AboutNeuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.Show more

Revenue $75M +5.0%
EBITDA -$32M -13.8%
Net Income -$44M -44.8%
EPS (Diluted) -1.38 -31.4%
Gross Margin 72.32% -0.2%
EBITDA Margin -43.38% -8.4%
Operating Margin -46.15% -7.8%
Net Margin -58.36% -37.9%
ROE -132.47% -100.2%
ROIC -39.29% +45.6%
Debt/Equity 2.60 +42.2%
Interest Coverage -4.74 +15.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗High debt to equity ratio of 2.6x
✗Weak Piotroski F-Score: 1/9
✗Negative free cash flow
✗Weak momentum: RS Rating 9 (bottom 9%)
✗Shares diluted 10.7% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y3.63%

3Y10.63%

TTM78.62%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-22.18%

EPS CAGR

10Y-

5Y-

3Y-

TTM33.33%

ROCE

10Y Avg-41.77%

5Y Avg-32.52%

3Y Avg-33.73%

Latest-33.61%

Peer Comparison

Digital Therapeutics & Remote Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STIMNeuronetics, Inc.	123.96M	1.81	-1.31	4.96%	-34.27%	-141.91%		2.60
DRIODarioHealth Corp.	82.59M	12.22	-20.03	32.86%	-137.17%	-45.27%		0.42

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	34.23M	40.43M	52.78M	62.66M	49.24M	55.31M	65.21M	71.35M	74.89M
Revenue Growth %	-	0.18%	0.31%	0.19%	-0.21%	0.12%	0.18%	0.09%	0.05%
Cost of Goods Sold+	6.62M	9.63M	12.45M	15.39M	11.55M	11.65M	15.48M	19.64M	20.73M
COGS % of Revenue	0.19%	0.24%	0.24%	0.25%	0.23%	0.21%	0.24%	0.28%	0.28%
Gross Profit+	27.61M	30.8M	40.33M	47.27M	37.69M	43.66M	49.72M	51.7M	54.16M
Gross Margin %	0.81%	0.76%	0.76%	0.75%	0.77%	0.79%	0.76%	0.72%	0.72%
Gross Profit Growth %	-	0.12%	0.31%	0.17%	-0.2%	0.16%	0.14%	0.04%	0.05%
Operating Expenses+	36.94M	44.41M	60.16M	74.2M	60M	71.22M	84.83M	82.26M	88.72M
OpEx % of Revenue	1.08%	1.1%	1.14%	1.18%	1.22%	1.29%	1.3%	1.15%	1.18%
Selling, General & Admin	28.72M	36.47M	51.93M	60.45M	50.8M	63.3M	75.5M	72.74M	75.95M
SG&A % of Revenue	0.84%	0.9%	0.98%	0.96%	1.03%	1.14%	1.16%	1.02%	1.01%
Research & Development	8.22M	7.94M	8.23M	13.75M	9.2M	7.92M	9.34M	9.52M	12.77M
R&D % of Revenue	0.24%	0.2%	0.16%	0.22%	0.19%	0.14%	0.14%	0.13%	0.17%
Other Operating Expenses	-62K	357K	-575K	0	0	0	0	0	0
Operating Income+	-9.34M	-13.61M	-19.83M	-26.93M	-22.31M	-27.56M	-35.11M	-30.55M	-34.56M
Operating Margin %	-0.27%	-0.34%	-0.38%	-0.43%	-0.45%	-0.5%	-0.54%	-0.43%	-0.46%
Operating Income Growth %	-	-0.46%	-0.46%	-0.36%	0.17%	-0.24%	-0.27%	0.13%	-0.13%
EBITDA+	-8.66M	-12.94M	-18.95M	-25.86M	-21.37M	-26.5M	-33.46M	-28.55M	-32.49M
EBITDA Margin %	-0.25%	-0.32%	-0.36%	-0.41%	-0.43%	-0.48%	-0.51%	-0.4%	-0.43%
EBITDA Growth %	-	-0.49%	-0.47%	-0.36%	0.17%	-0.24%	-0.26%	0.15%	-0.14%
D&A (Non-Cash Add-back)	673K	673K	882K	1.06M	941K	1.06M	1.65M	2.01M	2.07M
EBIT	-9.4M	-13.25M	-20.41M	-28.26M	-26.83M	-27.87M	-33.61M	-24.77M	-36.44M
Net Interest Income+	-1.83M	-2.81M	-3.69M	-3.69M	-4.52M	-3.3M	-3.6M	-5.4M	-7.3M
Interest Income	0	0	0	0	0	0	0	24K	0
Interest Expense	1.83M	2.81M	3.69M	3.69M	4.52M	3.3M	3.6M	5.42M	7.29M
Other Income/Expense	-1.9M	-2.45M	-4.26M	-2.11M	-5.14M	-3.61M	-2.1M	365K	-9.18M
Pretax Income+	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.17M	-37.21M	-30.19M	-43.74M
Pretax Margin %	-0.33%	-0.4%	-0.46%	-0.46%	-0.56%	-0.56%	-0.57%	-0.42%	-0.58%
Income Tax+	0	0	0	0	0	0	0	-24K	-14K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M	-43.71M
Net Margin %	-0.33%	-0.4%	-0.46%	-0.46%	-0.56%	-0.56%	-0.57%	-0.42%	-0.58%
Net Income Growth %	-	-0.43%	-0.5%	-0.21%	0.05%	-0.14%	-0.19%	0.19%	-0.45%
Net Income (Continuing)	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.17M	-37.21M	-30.16M	-43.73M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	4.09M
EPS (Diluted)+	-1001.25	-1431.28	-2.69	-1.87	-1.46	-1.22	-1.38	-1.05	-1.38
EPS Growth %	-	-0.43%	1%	0.3%	0.22%	0.16%	-0.13%	0.24%	-0.31%
EPS (Basic)	-1001.25	-1431.28	-2.69	-1.87	-1.46	-1.22	-1.38	-1.05	-1.38
Diluted Shares Outstanding	11.22K	11.22K	8.95M	18.38M	18.84M	25.48M	26.9M	28.66M	31.73M
Basic Shares Outstanding	11.22K	11.22K	8.95M	18.38M	18.84M	25.48M	26.9M	28.66M	31.73M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	22.92M	37.01M	114.47M	88.45M	65.01M	115.33M	98.77M	93.79M	58.12M
Cash & Short-Term Investments	17.04M	29.15M	104.58M	76.59M	50.84M	96.34M	71.88M	60.58M	19.66M
Cash Only	17.04M	29.15M	104.58M	75.71M	48.96M	94.14M	70.34M	59.68M	19.46M
Short-Term Investments	0	0	0	880K	1.89M	2.2M	1.54M	905K	206K
Accounts Receivable	3.58M	4.27M	5.62M	6.57M	7.17M	7.78M	13.82M	17.84M	24.29M
Days Sales Outstanding	38.14	38.52	38.87	38.27	53.11	51.34	77.36	91.26	118.36
Inventory	1.7M	2.47M	2.43M	2.77M	3.72M	6.56M	8.9M	8.09M	4.25M
Days Inventory Outstanding	93.48	93.52	71.32	65.82	117.52	205.57	209.79	150.38	74.8
Other Current Assets	607K	1.12M	1.84M	1.83M	2.19M	3.09M	2.17M	4.77M	6.85M
Total Non-Current Assets+	1.88M	1.93M	2.55M	11.72M	13.64M	25.89M	18.11M	22.04M	82.78M
Property, Plant & Equipment	1.63M	1.36M	1.38M	4.9M	4.15M	5.1M	5.32M	4.78M	33.34M
Fixed Asset Turnover	21.02x	29.75x	38.30x	12.78x	11.87x	10.84x	12.26x	14.92x	2.25x
Goodwill	0	0	0	0	0	0	0	0	18.63M
Intangible Assets	0	400K	1M	0	0	0	0	0	19.61M
Long-Term Investments	0	0	0	1.73M	2.33M	1.7M	1.22M	661K	86K
Other Non-Current Assets	250K	174K	171K	5.08M	7.17M	19.09M	11.57M	16.59M	11.12M
Total Assets+	24.8M	38.94M	117.02M	100.17M	78.66M	141.22M	116.88M	115.83M	140.9M
Asset Turnover	1.38x	1.04x	0.45x	0.63x	0.63x	0.39x	0.56x	0.62x	0.53x
Asset Growth %	-	0.57%	2.01%	-0.14%	-0.21%	0.8%	-0.17%	-0.01%	0.22%
Total Current Liabilities+	13.34M	11.99M	13.56M	27.69M	13.68M	15.7M	33.2M	19.81M	31.27M
Accounts Payable	1.48M	2.51M	3.76M	4.63M	3.75M	4.3M	2.43M	4.75M	11.08M
Days Payables Outstanding	81.74	95.23	110.14	109.7	118.43	134.66	57.36	88.3	195.05
Short-Term Debt	4.49M	0	0	11.25M	0	0	13.13M	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	974K
Other Current Liabilities	2.37M	2.72M	2.64M	5.72M	5.02M	5.09M	11.2M	8M	8.95M
Current Ratio	1.72x	3.09x	8.44x	3.19x	4.75x	7.34x	2.98x	4.73x	1.86x
Quick Ratio	1.59x	2.88x	8.26x	3.09x	4.48x	6.93x	2.71x	4.33x	1.72x
Cash Conversion Cycle	49.88	36.81	0.04	-5.61	52.2	122.25	229.8	153.34	-1.89
Total Non-Current Liabilities+	188.58M	219.6M	32.42M	24.62M	39.48M	40.34M	26.63M	61.83M	77.84M
Long-Term Debt	15.65M	29.56M	30.39M	19.9M	34.62M	35.34M	22.83M	59.28M	55.15M
Capital Lease Obligations	0	0	0	2.62M	3.12M	3.54M	2.97M	2.35M	22.69M
Deferred Tax Liabilities	-167K	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	172.94M	187.76M	86K	0	0	0	0	0	0
Total Liabilities	201.92M	231.59M	45.98M	52.32M	53.16M	56.05M	59.82M	81.64M	109.1M
Total Debt+	20.14M	29.56M	30.39M	34.33M	38.34M	39.54M	39.74M	62.47M	82.63M
Net Debt	3.1M	409K	-74.19M	-41.38M	-10.62M	-54.6M	-30.59M	2.8M	63.17M
Debt / Equity	-	-	0.43x	0.72x	1.50x	0.46x	0.70x	1.83x	2.60x
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-
Interest Coverage	-5.09x	-4.85x	-5.38x	-7.31x	-4.93x	-8.35x	-9.75x	-5.63x	-4.74x
Total Equity+	-177.12M	-192.65M	71.04M	47.85M	25.49M	85.17M	57.06M	34.19M	31.8M
Equity Growth %	-	-0.09%	1.37%	-0.33%	-0.47%	2.34%	-0.33%	-0.4%	-0.07%
Book Value per Share	-15786.45	-17170.41	7.94	2.60	1.35	3.34	2.12	1.19	1.00
Total Shareholders' Equity	-177.12M	-192.65M	71.04M	47.85M	25.49M	85.17M	57.06M	34.19M	27.71M
Common Stock	2K	2K	177K	186K	191K	264K	273K	291K	557K
Retained Earnings	-180.89M	-196.95M	-221.04M	-250.09M	-277.54M	-308.73M	-345.89M	-376.08M	-419.79M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	3.71M	4.23M	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	4.09M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-8.54M	-11.14M	-20.59M	-30.48M	-28.39M	-27.98M	-30.74M	-32.04M	-31M
Operating CF Margin %	-0.25%	-0.28%	-0.39%	-0.49%	-0.58%	-0.51%	-0.47%	-0.45%	-0.41%
Operating CF Growth %	-	-0.3%	-0.85%	-0.48%	0.07%	0.01%	-0.1%	-0.04%	0.03%
Net Income	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M	-43.73M
Depreciation & Amortization	673K	596K	882K	1.06M	941K	1.06M	1.65M	2.01M	2.07M
Stock-Based Compensation	161K	496K	1.74M	3.43M	4.4M	7.87M	8.75M	7.32M	5.6M
Deferred Taxes	108K	-271K	1.4M	0	0	0	0	0	0
Other Non-Cash Items	406K	938K	1.07M	976K	1.99M	918K	1.14M	2.93M	11.86M
Working Capital Changes	1.34M	3.16M	-1.58M	-6.91M	-8.28M	-6.64M	-5.12M	-14.1M	-6.81M
Change in Receivables	-123K	-690K	-1.35M	-950K	-597K	-3.05M	-6.66M	-8.83M	-3.73M
Change in Inventory	-646K	-1.07M	-435K	-306K	-945K	-3.44M	-2.59M	-1.1M	3.15M
Change in Payables	734K	788K	606K	299K	-1.08M	276K	-1.97M	2.03M	-1.99M
Cash from Investing+	-324K	-594K	-1.01M	-813K	-730K	-9.84M	6.73M	-1.32M	-2.41M
Capital Expenditures	-324K	-594K	-1.01M	-813K	-730K	-2.35M	-3.27M	-2.37M	-1.47M
CapEx % of Revenue	0.01%	0.01%	0.02%	0.01%	0.01%	0.04%	0.05%	0.03%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	2.61M	0	-7.81M	10M	1.05M	1.61M
Cash from Financing+	4.9M	23.84M	97.04M	2.42M	2.37M	83.01M	207K	22.7M	-6.81M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-104K	-980K	-2.96M	2.42M	-131K	2.03M	207K	-1.1M	-4.29M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-8.87M	-11.74M	-21.6M	-31.3M	-29.12M	-30.34M	-34.01M	-34.41M	-32.46M
FCF Margin %	-0.26%	-0.29%	-0.41%	-0.5%	-0.59%	-0.55%	-0.52%	-0.48%	-0.43%
FCF Growth %	-	-0.32%	-0.84%	-0.45%	0.07%	-0.04%	-0.12%	-0.01%	0.06%
FCF per Share	-790.11	-1046.17	-2.41	-1.70	-1.55	-1.19	-1.26	-1.20	-1.02
FCF Conversion (FCF/Net Income)	0.76x	0.69x	0.85x	1.05x	1.03x	0.90x	0.83x	1.06x	0.71x
Interest Paid	0	0	0	0	3.89M	0	3.54M	4.79M	6.51M
Taxes Paid	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-33.92%	-48.86%	-74.86%	-56.37%	-52.25%	-66.17%	-132.47%
Return on Invested Capital (ROIC)	-	-	-	-1215.25%	-156.8%	-90.97%	-92.33%	-72.23%	-39.29%
Gross Margin	80.65%	76.18%	76.42%	75.44%	76.54%	78.93%	76.26%	72.47%	72.32%
Net Margin	-32.82%	-39.72%	-45.66%	-46.35%	-55.75%	-56.39%	-56.99%	-42.31%	-58.36%
Debt / Equity	-	-	0.43x	0.72x	1.50x	0.46x	0.70x	1.83x	2.60x
Interest Coverage	-5.09x	-4.85x	-5.38x	-7.31x	-4.93x	-8.35x	-9.75x	-5.63x	-4.74x
FCF Conversion	0.76x	0.69x	0.85x	1.05x	1.03x	0.90x	0.83x	1.06x	0.71x
Revenue Growth	-	18.13%	30.53%	18.72%	-21.41%	12.32%	17.89%	9.42%	4.96%

Revenue by Segment

	2024
Medical Device	74.89M
Medical Device Growth	-

Frequently Asked Questions

Growth & Financials

Neuronetics, Inc. (STIM) reported $129.9M in revenue for fiscal year 2024. This represents a 279% increase from $34.2M in 2016.

Neuronetics, Inc. (STIM) grew revenue by 5.0% over the past year. Growth has been modest.

Neuronetics, Inc. (STIM) reported a net loss of $44.5M for fiscal year 2024.

Dividend & Returns

Neuronetics, Inc. (STIM) has a return on equity (ROE) of -132.5%. Negative ROE indicates the company is unprofitable.

Neuronetics, Inc. (STIM) had negative free cash flow of $30.6M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Neuronetics, Inc. (STIM) 10-Year Financial Performance & Capital Metrics

STIM • • Industrial / General

HealthcareDiagnostics & ResearchDigital Health & Point-of-Care DiagnosticsDigital Therapeutics & Remote Monitoring

Revenue $75M +5.0%
EBITDA -$32M -13.8%
Net Income -$44M -44.8%
EPS (Diluted) -1.38 -31.4%
Gross Margin 72.32% -0.2%
EBITDA Margin -43.38% -8.4%
Operating Margin -46.15% -7.8%
Net Margin -58.36% -37.9%
ROE -132.47% -100.2%
ROIC -39.29% +45.6%
Debt/Equity 2.60 +42.2%
Interest Coverage -4.74 +15.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗High debt to equity ratio of 2.6x
✗Weak Piotroski F-Score: 1/9
✗Negative free cash flow
✗Weak momentum: RS Rating 9 (bottom 9%)
✗Shares diluted 10.7% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y3.63%

3Y10.63%

TTM78.62%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-22.18%

EPS CAGR

10Y-

5Y-

3Y-

TTM33.33%

ROCE

10Y Avg-41.77%

5Y Avg-32.52%

3Y Avg-33.73%

Latest-33.61%

Peer Comparison

Digital Therapeutics & Remote Monitoring

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STIMNeuronetics, Inc.	123.96M	1.81	-1.31	4.96%	-34.27%	-141.91%		2.60
DRIODarioHealth Corp.	82.59M	12.22	-20.03	32.86%	-137.17%	-45.27%		0.42

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	34.23M	40.43M	52.78M	62.66M	49.24M	55.31M	65.21M	71.35M	74.89M
Revenue Growth %	-	0.18%	0.31%	0.19%	-0.21%	0.12%	0.18%	0.09%	0.05%
Cost of Goods Sold+	6.62M	9.63M	12.45M	15.39M	11.55M	11.65M	15.48M	19.64M	20.73M
COGS % of Revenue	0.19%	0.24%	0.24%	0.25%	0.23%	0.21%	0.24%	0.28%	0.28%
Gross Profit+	27.61M	30.8M	40.33M	47.27M	37.69M	43.66M	49.72M	51.7M	54.16M
Gross Margin %	0.81%	0.76%	0.76%	0.75%	0.77%	0.79%	0.76%	0.72%	0.72%
Gross Profit Growth %	-	0.12%	0.31%	0.17%	-0.2%	0.16%	0.14%	0.04%	0.05%
Operating Expenses+	36.94M	44.41M	60.16M	74.2M	60M	71.22M	84.83M	82.26M	88.72M
OpEx % of Revenue	1.08%	1.1%	1.14%	1.18%	1.22%	1.29%	1.3%	1.15%	1.18%
Selling, General & Admin	28.72M	36.47M	51.93M	60.45M	50.8M	63.3M	75.5M	72.74M	75.95M
SG&A % of Revenue	0.84%	0.9%	0.98%	0.96%	1.03%	1.14%	1.16%	1.02%	1.01%
Research & Development	8.22M	7.94M	8.23M	13.75M	9.2M	7.92M	9.34M	9.52M	12.77M
R&D % of Revenue	0.24%	0.2%	0.16%	0.22%	0.19%	0.14%	0.14%	0.13%	0.17%
Other Operating Expenses	-62K	357K	-575K	0	0	0	0	0	0
Operating Income+	-9.34M	-13.61M	-19.83M	-26.93M	-22.31M	-27.56M	-35.11M	-30.55M	-34.56M
Operating Margin %	-0.27%	-0.34%	-0.38%	-0.43%	-0.45%	-0.5%	-0.54%	-0.43%	-0.46%
Operating Income Growth %	-	-0.46%	-0.46%	-0.36%	0.17%	-0.24%	-0.27%	0.13%	-0.13%
EBITDA+	-8.66M	-12.94M	-18.95M	-25.86M	-21.37M	-26.5M	-33.46M	-28.55M	-32.49M
EBITDA Margin %	-0.25%	-0.32%	-0.36%	-0.41%	-0.43%	-0.48%	-0.51%	-0.4%	-0.43%
EBITDA Growth %	-	-0.49%	-0.47%	-0.36%	0.17%	-0.24%	-0.26%	0.15%	-0.14%
D&A (Non-Cash Add-back)	673K	673K	882K	1.06M	941K	1.06M	1.65M	2.01M	2.07M
EBIT	-9.4M	-13.25M	-20.41M	-28.26M	-26.83M	-27.87M	-33.61M	-24.77M	-36.44M
Net Interest Income+	-1.83M	-2.81M	-3.69M	-3.69M	-4.52M	-3.3M	-3.6M	-5.4M	-7.3M
Interest Income	0	0	0	0	0	0	0	24K	0
Interest Expense	1.83M	2.81M	3.69M	3.69M	4.52M	3.3M	3.6M	5.42M	7.29M
Other Income/Expense	-1.9M	-2.45M	-4.26M	-2.11M	-5.14M	-3.61M	-2.1M	365K	-9.18M
Pretax Income+	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.17M	-37.21M	-30.19M	-43.74M
Pretax Margin %	-0.33%	-0.4%	-0.46%	-0.46%	-0.56%	-0.56%	-0.57%	-0.42%	-0.58%
Income Tax+	0	0	0	0	0	0	0	-24K	-14K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M	-43.71M
Net Margin %	-0.33%	-0.4%	-0.46%	-0.46%	-0.56%	-0.56%	-0.57%	-0.42%	-0.58%
Net Income Growth %	-	-0.43%	-0.5%	-0.21%	0.05%	-0.14%	-0.19%	0.19%	-0.45%
Net Income (Continuing)	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.17M	-37.21M	-30.16M	-43.73M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	4.09M
EPS (Diluted)+	-1001.25	-1431.28	-2.69	-1.87	-1.46	-1.22	-1.38	-1.05	-1.38
EPS Growth %	-	-0.43%	1%	0.3%	0.22%	0.16%	-0.13%	0.24%	-0.31%
EPS (Basic)	-1001.25	-1431.28	-2.69	-1.87	-1.46	-1.22	-1.38	-1.05	-1.38
Diluted Shares Outstanding	11.22K	11.22K	8.95M	18.38M	18.84M	25.48M	26.9M	28.66M	31.73M
Basic Shares Outstanding	11.22K	11.22K	8.95M	18.38M	18.84M	25.48M	26.9M	28.66M	31.73M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	22.92M	37.01M	114.47M	88.45M	65.01M	115.33M	98.77M	93.79M	58.12M
Cash & Short-Term Investments	17.04M	29.15M	104.58M	76.59M	50.84M	96.34M	71.88M	60.58M	19.66M
Cash Only	17.04M	29.15M	104.58M	75.71M	48.96M	94.14M	70.34M	59.68M	19.46M
Short-Term Investments	0	0	0	880K	1.89M	2.2M	1.54M	905K	206K
Accounts Receivable	3.58M	4.27M	5.62M	6.57M	7.17M	7.78M	13.82M	17.84M	24.29M
Days Sales Outstanding	38.14	38.52	38.87	38.27	53.11	51.34	77.36	91.26	118.36
Inventory	1.7M	2.47M	2.43M	2.77M	3.72M	6.56M	8.9M	8.09M	4.25M
Days Inventory Outstanding	93.48	93.52	71.32	65.82	117.52	205.57	209.79	150.38	74.8
Other Current Assets	607K	1.12M	1.84M	1.83M	2.19M	3.09M	2.17M	4.77M	6.85M
Total Non-Current Assets+	1.88M	1.93M	2.55M	11.72M	13.64M	25.89M	18.11M	22.04M	82.78M
Property, Plant & Equipment	1.63M	1.36M	1.38M	4.9M	4.15M	5.1M	5.32M	4.78M	33.34M
Fixed Asset Turnover	21.02x	29.75x	38.30x	12.78x	11.87x	10.84x	12.26x	14.92x	2.25x
Goodwill	0	0	0	0	0	0	0	0	18.63M
Intangible Assets	0	400K	1M	0	0	0	0	0	19.61M
Long-Term Investments	0	0	0	1.73M	2.33M	1.7M	1.22M	661K	86K
Other Non-Current Assets	250K	174K	171K	5.08M	7.17M	19.09M	11.57M	16.59M	11.12M
Total Assets+	24.8M	38.94M	117.02M	100.17M	78.66M	141.22M	116.88M	115.83M	140.9M
Asset Turnover	1.38x	1.04x	0.45x	0.63x	0.63x	0.39x	0.56x	0.62x	0.53x
Asset Growth %	-	0.57%	2.01%	-0.14%	-0.21%	0.8%	-0.17%	-0.01%	0.22%
Total Current Liabilities+	13.34M	11.99M	13.56M	27.69M	13.68M	15.7M	33.2M	19.81M	31.27M
Accounts Payable	1.48M	2.51M	3.76M	4.63M	3.75M	4.3M	2.43M	4.75M	11.08M
Days Payables Outstanding	81.74	95.23	110.14	109.7	118.43	134.66	57.36	88.3	195.05
Short-Term Debt	4.49M	0	0	11.25M	0	0	13.13M	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	974K
Other Current Liabilities	2.37M	2.72M	2.64M	5.72M	5.02M	5.09M	11.2M	8M	8.95M
Current Ratio	1.72x	3.09x	8.44x	3.19x	4.75x	7.34x	2.98x	4.73x	1.86x
Quick Ratio	1.59x	2.88x	8.26x	3.09x	4.48x	6.93x	2.71x	4.33x	1.72x
Cash Conversion Cycle	49.88	36.81	0.04	-5.61	52.2	122.25	229.8	153.34	-1.89
Total Non-Current Liabilities+	188.58M	219.6M	32.42M	24.62M	39.48M	40.34M	26.63M	61.83M	77.84M
Long-Term Debt	15.65M	29.56M	30.39M	19.9M	34.62M	35.34M	22.83M	59.28M	55.15M
Capital Lease Obligations	0	0	0	2.62M	3.12M	3.54M	2.97M	2.35M	22.69M
Deferred Tax Liabilities	-167K	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	172.94M	187.76M	86K	0	0	0	0	0	0
Total Liabilities	201.92M	231.59M	45.98M	52.32M	53.16M	56.05M	59.82M	81.64M	109.1M
Total Debt+	20.14M	29.56M	30.39M	34.33M	38.34M	39.54M	39.74M	62.47M	82.63M
Net Debt	3.1M	409K	-74.19M	-41.38M	-10.62M	-54.6M	-30.59M	2.8M	63.17M
Debt / Equity	-	-	0.43x	0.72x	1.50x	0.46x	0.70x	1.83x	2.60x
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-
Interest Coverage	-5.09x	-4.85x	-5.38x	-7.31x	-4.93x	-8.35x	-9.75x	-5.63x	-4.74x
Total Equity+	-177.12M	-192.65M	71.04M	47.85M	25.49M	85.17M	57.06M	34.19M	31.8M
Equity Growth %	-	-0.09%	1.37%	-0.33%	-0.47%	2.34%	-0.33%	-0.4%	-0.07%
Book Value per Share	-15786.45	-17170.41	7.94	2.60	1.35	3.34	2.12	1.19	1.00
Total Shareholders' Equity	-177.12M	-192.65M	71.04M	47.85M	25.49M	85.17M	57.06M	34.19M	27.71M
Common Stock	2K	2K	177K	186K	191K	264K	273K	291K	557K
Retained Earnings	-180.89M	-196.95M	-221.04M	-250.09M	-277.54M	-308.73M	-345.89M	-376.08M	-419.79M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	3.71M	4.23M	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	4.09M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-8.54M	-11.14M	-20.59M	-30.48M	-28.39M	-27.98M	-30.74M	-32.04M	-31M
Operating CF Margin %	-0.25%	-0.28%	-0.39%	-0.49%	-0.58%	-0.51%	-0.47%	-0.45%	-0.41%
Operating CF Growth %	-	-0.3%	-0.85%	-0.48%	0.07%	0.01%	-0.1%	-0.04%	0.03%
Net Income	-11.23M	-16.06M	-24.1M	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M	-43.73M
Depreciation & Amortization	673K	596K	882K	1.06M	941K	1.06M	1.65M	2.01M	2.07M
Stock-Based Compensation	161K	496K	1.74M	3.43M	4.4M	7.87M	8.75M	7.32M	5.6M
Deferred Taxes	108K	-271K	1.4M	0	0	0	0	0	0
Other Non-Cash Items	406K	938K	1.07M	976K	1.99M	918K	1.14M	2.93M	11.86M
Working Capital Changes	1.34M	3.16M	-1.58M	-6.91M	-8.28M	-6.64M	-5.12M	-14.1M	-6.81M
Change in Receivables	-123K	-690K	-1.35M	-950K	-597K	-3.05M	-6.66M	-8.83M	-3.73M
Change in Inventory	-646K	-1.07M	-435K	-306K	-945K	-3.44M	-2.59M	-1.1M	3.15M
Change in Payables	734K	788K	606K	299K	-1.08M	276K	-1.97M	2.03M	-1.99M
Cash from Investing+	-324K	-594K	-1.01M	-813K	-730K	-9.84M	6.73M	-1.32M	-2.41M
Capital Expenditures	-324K	-594K	-1.01M	-813K	-730K	-2.35M	-3.27M	-2.37M	-1.47M
CapEx % of Revenue	0.01%	0.01%	0.02%	0.01%	0.01%	0.04%	0.05%	0.03%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	2.61M	0	-7.81M	10M	1.05M	1.61M
Cash from Financing+	4.9M	23.84M	97.04M	2.42M	2.37M	83.01M	207K	22.7M	-6.81M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-104K	-980K	-2.96M	2.42M	-131K	2.03M	207K	-1.1M	-4.29M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-8.87M	-11.74M	-21.6M	-31.3M	-29.12M	-30.34M	-34.01M	-34.41M	-32.46M
FCF Margin %	-0.26%	-0.29%	-0.41%	-0.5%	-0.59%	-0.55%	-0.52%	-0.48%	-0.43%
FCF Growth %	-	-0.32%	-0.84%	-0.45%	0.07%	-0.04%	-0.12%	-0.01%	0.06%
FCF per Share	-790.11	-1046.17	-2.41	-1.70	-1.55	-1.19	-1.26	-1.20	-1.02
FCF Conversion (FCF/Net Income)	0.76x	0.69x	0.85x	1.05x	1.03x	0.90x	0.83x	1.06x	0.71x
Interest Paid	0	0	0	0	3.89M	0	3.54M	4.79M	6.51M
Taxes Paid	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-33.92%	-48.86%	-74.86%	-56.37%	-52.25%	-66.17%	-132.47%
Return on Invested Capital (ROIC)	-	-	-	-1215.25%	-156.8%	-90.97%	-92.33%	-72.23%	-39.29%
Gross Margin	80.65%	76.18%	76.42%	75.44%	76.54%	78.93%	76.26%	72.47%	72.32%
Net Margin	-32.82%	-39.72%	-45.66%	-46.35%	-55.75%	-56.39%	-56.99%	-42.31%	-58.36%
Debt / Equity	-	-	0.43x	0.72x	1.50x	0.46x	0.70x	1.83x	2.60x
Interest Coverage	-5.09x	-4.85x	-5.38x	-7.31x	-4.93x	-8.35x	-9.75x	-5.63x	-4.74x
FCF Conversion	0.76x	0.69x	0.85x	1.05x	1.03x	0.90x	0.83x	1.06x	0.71x
Revenue Growth	-	18.13%	30.53%	18.72%	-21.41%	12.32%	17.89%	9.42%	4.96%

Revenue by Segment

	2024
Medical Device	74.89M
Medical Device Growth	-

Frequently Asked Questions

Growth & Financials

Neuronetics, Inc. (STIM) reported $129.9M in revenue for fiscal year 2024. This represents a 279% increase from $34.2M in 2016.

Neuronetics, Inc. (STIM) grew revenue by 5.0% over the past year. Growth has been modest.

Neuronetics, Inc. (STIM) reported a net loss of $44.5M for fiscal year 2024.

Dividend & Returns

Neuronetics, Inc. (STIM) has a return on equity (ROE) of -132.5%. Negative ROE indicates the company is unprofitable.

Neuronetics, Inc. (STIM) had negative free cash flow of $30.6M in fiscal year 2024, likely due to heavy capital investments.